These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10934521)

  • 1. Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems. An update.
    Caughey B; Raymond GJ; Priola SA; Kocisko DA; Race RE; Bessen RA; Lansbury PT; Chesebro B
    Mol Biotechnol; 1999 Nov; 13(1):45-55. PubMed ID: 10934521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of protease-resistant prion protein in cell-free systems.
    Caughey B
    Curr Issues Mol Biol; 2000 Jul; 2(3):95-101. PubMed ID: 11471561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines.
    Caughey WS; Raymond LD; Horiuchi M; Caughey B
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12117-22. PubMed ID: 9770449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion protein and species barriers in the transmissible spongiform encephalopathies.
    Priola SA
    Biomed Pharmacother; 1999; 53(1):27-33. PubMed ID: 10221165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting interactions between prion protein isoforms.
    Caughey B; Baron GS
    Biochem Soc Trans; 2002 Aug; 30(4):565-9. PubMed ID: 12196138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro.
    Lawson VA; Priola SA; Wehrly K; Chesebro B
    J Biol Chem; 2001 Sep; 276(38):35265-71. PubMed ID: 11466311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylation influences cross-species formation of protease-resistant prion protein.
    Priola SA; Lawson VA
    EMBO J; 2001 Dec; 20(23):6692-9. PubMed ID: 11726505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flexible N-terminal region of prion protein influences conformation of protease-resistant prion protein isoforms associated with cross-species scrapie infection in vivo and in vitro.
    Lawson VA; Priola SA; Meade-White K; Lawson M; Chesebro B
    J Biol Chem; 2004 Apr; 279(14):13689-95. PubMed ID: 14736880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155.
    Priola SA; Chabry J; Chan K
    J Virol; 2001 May; 75(10):4673-80. PubMed ID: 11312338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform.
    Vorberg I; Chan K; Priola SA
    J Virol; 2001 Nov; 75(21):10024-32. PubMed ID: 11581371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices.
    Bessen RA; Raymond GJ; Caughey B
    J Biol Chem; 1997 Jun; 272(24):15227-31. PubMed ID: 9182546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cells expressing anchorless prion protein are resistant to scrapie infection.
    McNally KL; Ward AE; Priola SA
    J Virol; 2009 May; 83(9):4469-75. PubMed ID: 19225008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
    Horiuchi M; Caughey B
    EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers.
    Horiuchi M; Priola SA; Chabry J; Caughey B
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5836-41. PubMed ID: 10811921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells.
    Priola SA; Chesebro B
    J Virol; 1995 Dec; 69(12):7754-8. PubMed ID: 7494285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state.
    Caughey B; Raymond GJ; Ernst D; Race RE
    J Virol; 1991 Dec; 65(12):6597-603. PubMed ID: 1682507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congo red analogues as potential anti-prion agents.
    Villa S; Cignarella G; Barlocco D; Gervasoni M; Carcassola G; Giannino L; Mantegazza P
    Farmaco; 2003 Sep; 58(9):929-37. PubMed ID: 13679188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.
    Wong C; Xiong LW; Horiuchi M; Raymond L; Wehrly K; Chesebro B; Caughey B
    EMBO J; 2001 Feb; 20(3):377-86. PubMed ID: 11157745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion protein conversions: insight into mechanisms, TSE transmission barriers and strains.
    Caughey B
    Br Med Bull; 2003; 66():109-20. PubMed ID: 14522853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-free formation of protease-resistant prion protein.
    Kocisko DA; Come JH; Priola SA; Chesebro B; Raymond GJ; Lansbury PT; Caughey B
    Nature; 1994 Aug; 370(6489):471-4. PubMed ID: 7913989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.